G
ISSUER//CIK 0001656634
Gritstone bio, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K467.2 KBGritstone bio, Inc.Apr 4, 4:05 PM ET·0001193125-25-073396
- 8-K5.8 MBGritstone bio, Inc.Feb 25, 5:13 PM ET·0001193125-25-035266
- 8-K5.5 MBGritstone bio, Inc.Feb 14, 4:05 PM ET·0001193125-25-027252
- 8-K468.3 KBGritstone bio, Inc.Jan 3, 4:05 PM ET·0001193125-25-001488
- 8-K146.0 KBGritstone bio, Inc.Dec 13, 4:35 PM ET·0001193125-24-278626
- 8-K5.9 MBGritstone bio, Inc.Nov 29, 4:05 PM ET·0001193125-24-268089
- SC 13G/A17.9 KBGritstone bio, Inc.Nov 7, 5:06 PM ET·0000895421-24-000584
- SC 13G/A17.6 KBGritstone bio, Inc.Nov 6, 5:34 PM ET·0000895421-24-000533
- 8-K146.3 KBGritstone bio, Inc.Oct 16, 4:06 PM ET·0001193125-24-238117
- 8-K186.9 KBGritstone bio, Inc.Oct 10, 8:29 AM ET·0001193125-24-235637
Insiders
10- Agarwal ShefaliDirector
- Allen Andrew RDirector, President and CEO
- Aphale JayantSee Remarks
- Bellemin Jean-MarcExecutive VP of Finance & CFO
- Cho JamesSVP, CHIEF ACCOUNTING OFFICER
- Clarus Lifesciences III, L.P.10% Owner
- Clarus Ventures III GP, L.P.General Partner
- Column Group II GP, LPgeneral partner
- COLUMN GROUP II, LP10% Owner
- Corey LawrenceDirector
Tickers
No tickers on record
Addresses
business
5959 HORTON STREET, SUITE 300
EMERYVILLE, CA, 94608
mailing
5959 HORTON STREET, SUITE 300
EMERYVILLE, CA, 94608
Former Names
- Gritstone Oncology, Inc.2021-04-23